Abstract
Paroxysmal supraventricular tachycardia is a common arrhythmia with multiple etiologies, including atrio-ventricular nodal reentrant tachycardia, atrio-ventricular reentrant tachycardia, and atrial tachycardia. Treatment of these arrhythmias depends greatly upon the proper diagnosis as well as an understanding of the arrhythmia’s mechanism. A preliminary diagnosis can be often be inferred from the patient’s history along with noninvasive testing and can help guide initial management strategies. Pharmacologic therapy, however, is often limited by side effects, compliance, and marginal efficacy. More definitive treatment of the arrhythmia requires an invasive electrophysiology study to confirm the diagnosis followed by catheter ablation of the arrhythmogenic substrate. The success rate for catheter ablation can approach 95% depending on the mechanism of the arrhythmia and is the treatment of choice for patients with severe symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Orejarena LA, Vidaillet HJ, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, Hayes JJ (1998) Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 31:150–157
Gonzalez-Torrecilla E, Almendral J, Arenal A, Atienza F, Atea LF, del Castillo S, Fernandez-Aviles F (2009) Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol 53:2353–2358
Zimetbaum P, Josephson ME (1998) Evaluation of patients with palpitations. N Engl J Med 338:1369–1373
Wood KA, Drew BJ, Scheinman MM (1997) Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol 79:145–149
Ferguson JD, DiMarco JP (2003) Contemporary management of paroxysmal supraventricular tachycardia. Circulation 107:1096–1099
Wellens HJ (1996) The value of the ECG in the diagnosis of supraventricular tachycardias. Eur Heart J 17(Suppl C):10–20
Kumar UN, Rao RK, Scheinman MM (2006) The 12-lead electrocardiogram in supraventricular tachycardia. Cardiol Clin 24:427–37, ix
Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ, Morady F (1993) Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol 21:85–89
Man KC, Brinkman K, Bogun F, Knight B, Bahu M, Weiss R, Goyal R, Harvey M, Daoud EG, Strickberger SA, Morady F (1996) 2:1 atrioventricular block during atrioventricular node reentrant tachycardia. J Am Coll Cardiol 28:1770–1774
Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CWJ, Stevenson WG, Tomaselli GF, Antman EM, Smith SCJ, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell ROJ, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ (2003) ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias). Circulation 108:1871–1909
Ganz LI, Friedman PL (1995) Supraventricular tachycardia. N Engl J Med 332:162–173
Shah D, Jais P, Haissaguerre M (2002) Electrophysiological evaluation and ablation of atypical right atrial flutter. Card Electrophysiol Rev 6:365–370
Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A (1993) Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 88:282–295
Cranefield PF (1977) Action potentials, afterpotentials, and arrhythmias. Circ Res 41:415–423
Wit AL, Rosen MR (1983) Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J 106:798–811
Akhtar M, Tchou PJ, Jazayeri M (1988) Mechanisms of clinical tachycardias. Am J Cardiol 61:9A–19A; Marchlinski FE, Miller JM (1985) Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man. Chest 88:931–934
Pappone C, Santinelli V, Rosanio S, Vicedomini G, Nardi S, Pappone A, Tortoriello V, Manguso F, Mazzone P, Gulletta S, Oreto G, Alfieri O (2003) Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41:239–244
Waxman MB, Wald RW, Sharma AD, Huerta F, Cameron DA (1980) Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol 46:655–664
Gonzalez R, Scheinman MM (1981) Treatment of supraventricular arrhythmias with intravenous and oral verapamil. Chest 80:465–470
DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68:1254–1263
Pelleg A, Pennock RS, Kutalek SP (2002) Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 9:141–147
Kaltman JR, Tanel RE, Shah MJ, Vetter VL, Rhodes LA (2006) Induction of atrial fibrillation after the routine use of adenosine. Pediatr Emerg Care 22:113–115
Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Knight BP, Weiss R, Bahu M, Morady F (1997) Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med 127:417–422
Iwai S, Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Das MK, Cohen JD, Hao SC, Lerman BB (2002) Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping. Circulation 106:2793–2799
Gulamhusein S, Ko P, Carruthers SG, Klein GJ (1982) Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation 65:348–354
Jacob AS, Nielsen DH, Gianelly RE (1985) Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation. Ann Emerg Med 14:159–160
Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Lerman BB (1999) Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 10:489–502
Wellens HJ, Durrer D (1974) Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome. Circulation 50:114–120
Windle J, Prystowsky EN, Miles WM, Heger JJ (1987) Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide. Clin Pharmacol Ther 41:603–610
Saoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M, Saksena S, Salerno J, Schoels W (2001) Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European society of cardiology and the North American society of pacing and electrophysiology. J Cardiovasc Electrophysiol 12:852–866
Glatter KA, Dorostkar PC, Yang Y, Lee RJ, Van Hare GF, Keung E, Modin G, Scheinman MM (2001) Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation 104:1933–1939
Akhtar M, Tchou P, Jazayeri M (1989) Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. Circulation 80:IV31–IV39
Gmeiner R, Ng CK (1982) Metoprolol in the treatment and prophylaxis of paroxysmal reentrant supraventricular tachycardia. J Cardiovasc Pharmacol 4:5–13
Lindsay BD, Saksena S, Rothbart ST, Herman S, Barr MJ (1987) Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia. Am J Cardiol 60:63D–67D
Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ (1983) Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Am J Cardiol 51:770–776
Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ (1996) A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide multicenter investigators group. Am J Cardiol 77:89A–95A
Ward DE, Jones S, Shinebourne EA (1986) Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome. Am J Cardiol 57:787–790
Musto B, D’Onofrio A, Cavallaro C, Musto A (1988) Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Circulation 78:863–869
Musto B, D’Onofrio A, Cavallaro C, Musto A, Greco R (1988) Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Am J Cardiol 62:229–233
Kim SS, Lal R, Ruffy R (1986) Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. Am J Cardiol 58:80–85
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac arrhythmia suppression trial.N Engl J Med 324:781–788
Mitchell LB, Wyse DG, Duff HJ (1987) Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome. Circulation 76:810–818
Kunze KP, Schluter M, Kuck KH (1987) Sotalol in patients with Wolff-Parkinson-White syndrome. Circulation 75:1050–1057
Tendera M, Wnuk-Wojnar AM, Kulakowski P, Malolepszy J, Kozlowski JW, Krzeminska-Pakula M, Szechinski J, Droszcz W, Kawecka-Jaszcz K, Swiatecka G, Ruzyllo W, Graff O (2001) Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J 142:93–98
Kobayashi Y, Atarashi H, Ino T, Kuruma A, Nomura A, Saitoh H, Hayakawa H (1997) Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias. J Cardiovasc Pharmacol 30:367–373
Rosenbaum MB, Chiale PA, Ryba D, Elizari MV (1974) Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 34:215–223
Wellens HJ, Lie KI, Bar FW, Wesdorp JC, Dohmen HJ, Duren DR, Durrer D (1976) Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol 38:189–194
Feld GK, Nademanee K, Weiss J, Stevenson W, Singh BN (1984) Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. J Am Coll Cardiol 3:1298–1307
Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fuca G, Brignole M, Cappato R (2001) Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 37:548–553
Rae AP (1998) Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias. Am J Cardiol 82:59 N–65 N
Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L (1992) Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J 124:110–115
Rose JS, Bhandari A, Rahimtoola SH, Wu D (1986) Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil. Am Heart J 112:759–765
Yeh SJ, Lin FC, Chou YY, Hung JS, Wu D (1985) Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol. Circulation 71:104–109
Cossu SF, Rothman SA, Chmielewski IL, Hsia HH, Vogel RL, Miller JM, Buxton AE (1997) The effects of isoproterenol on the cardiac conduction system: site-specific dose dependence. J Cardiovasc Electrophysiol 8:847–853
Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, Chiang BN, Chang MS (1994) Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 90:1262–1278
Wu D, Denes P, Dhingra R, Wyndham C, Rosen KM (1975) Determinants of fast- and slow-pathway conduction in patients with dual atrioventricular nodal pathways. Circ Res 36:782–790
Patruno N, Critelli G, Pulignano G, Urbani P, Villanti P, Reale A (1989) [Asymptomatic pre-excitation. Identification of potential risk using transesophageal pacing]. Cardiologia 34:777–781
Sung RJ, Waxman HL, Saksena S, Juma Z (1981) Sequence of retrograde atrial activation in patients with dual atrioventricular nodal pathways. Circulation 64:1059–1067
Hirao K, Otomo K, Wang X, Beckman KJ, McClelland JH, Widman L, Gonzalez MD, Arruda M, Nakagawa H, Lazzara R, Jackman WM (1996) Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 94:1027–1035
Strasberg B, Swiryn S, Bauernfeind R, Palileo E, Scagliotti D, Duffy CE, Rosen KM (1981) Retrograde dual atrioventricular nodal pathways. Am J Cardiol 48:639–646
Benditt DG, Pritchett EL, Smith WM, Gallagher JJ (1979) Ventriculoatrial intervals: diagnostic use in paroxysmal supraventricular tachycardia. Ann Intern Med 91:161–166
Coumel P, Attuel P (1974) Reciprocating tachycardia in overt and latent preexcitation. Influence of functional bundle branch block on the rate of the tachycardia. Eur J Cardiol 1:423–436
Sellers TDJ, Gallagher JJ, Cope GD, Tonkin AM, Wallace AG (1976) Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome. Eur J Cardiol 4:283–294
Knight BP, Ebinger M, Oral H, Kim MH, Sticherling C, Pelosi F, Michaud GF, Strickberger SA, Morady F (2000) Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 36:574–582
Michaud GF, Tada H, Chough S, Baker R, Wasmer K, Sticherling C, Oral H, Pelosi FJ, Knight BP, Strickberger SA, Morady F (2001) Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol 38:1163–1167
McGuire MA, Lau KC, Johnson DC, Richards DA, Uther JB, Ross DL (1991) Patients with two types of atrioventricular junctional (AV nodal) reentrant tachycardia. Evidence that a common pathway of nodal tissue is not present above the reentrant circuit. Circulation 83:1232–1246
Janse MJ, Anderson RH, McGuire MA, Ho SY (1993) “AV nodal” reentry: part I: “AV nodal” reentry revisited. J Cardiovasc Electrophysiol 4:561–572
McGuire MA, Bourke JP, Robotin MC, Johnson DC, Meldrum-Hanna W, Nunn GR, Uther JB, Ross DL (1993) High resolution mapping of Koch’s triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation 88:2315–2328
Kalbfleisch SJ, Strickberger SA, Williamson B, Vorperian VR, Man C, Hummel JD, Langberg JJ, Morady F (1994) Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 23:716–723
Lee MA, Morady F, Kadish A, Schamp DJ, Chin MC, Scheinman MM, Griffin JC, Lesh MD, Pederson D, Goldberger J et al (1991) Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia. Circulation 83:827–835
Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI et al (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327:313–318
Yamabe H, Okumura K, Tsuchiya T, Tabuchi T, Iwasa A, Yasue H (1998) Slow potential-guided radiofrequency catheter ablation in atrioventricular nodal reentrant tachycardia: characteristics of the potential associated with successful ablation. Pacing Clin Electrophysiol 21:2631–2640
Jentzer JH, Goyal R, Williamson BD, Man KC, Niebauer M, Daoud E, Strickberger SA, Hummel JD, Morady F (1994) Analysis of junctional ectopy during radiofrequency ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia. Circulation 90:2820–2826
Lipscomb KJ, Zaidi AM, Fitzpatrick AP, Lefroy D (2001) Slow pathway modification for atrioventricular node re-entrant tachycardia: fast junctional tachycardia predicts adverse prognosis. Heart 85:44–47
Lindsay BD, Chung MK, Gamache MC, Luke RA, Schechtman KB, Osborn JL, Cain ME (1993) Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current. J Am Coll Cardiol 22:733–740
Strickberger SA, Kalbfleisch SJ, Williamson B, Man KC, Vorperian V, Hummel JD, Langberg JJ, Morady F (1993) Radiofrequency catheter ablation of atypical atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 4:526–532
Clague JR, Dagres N, Kottkamp H, Breithardt G, Borggrefe M (2001) Targeting the slow pathway for atrioventricular nodal reentrant tachycardia: initial results and long-term follow-up in 379 consecutive patients. Eur Heart J 22:82–88
Haissaguerre M, Gaita F, Fischer B, Commenges D, Montserrat P, d'Ivernois C, Lemetayer P, Warin JF (1992) Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85:2162–2175
Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr multicenter investigators group. Circulation 99:262–270
Scheinman MM, Huang S (2000) The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 23:1020–1028
Hummel JD, Strickberger SA, Williamson BD, Man KC, Daoud E, Niebauer M, Bakr O, Morady F (1995) Effect of residual slow pathway function on the time course of recurrences of atrioventricular nodal reentrant tachycardia after radiofrequency ablation of the slow pathway. Am J Cardiol 75:628–630
Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM (2006) P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 48:1010–1017
Tang CW, Scheinman MM, Van Hare GF, Epstein LM, Fitzpatrick AP, Lee RJ, Lesh MD (1995) Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol 26:1315–1324
Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ (2004) Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 1:393–396
Walsh EP, Saul JP, Hulse JE, Rhodes LA, Hordof AJ, Mayer JE, Lock JE (1992) Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation 86:1138–1146
Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ, Kwasman MA, Grogin HR, Griffin JC (1994) Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation 89:1074–1089
Schmitt C, Zrenner B, Schneider M, Karch M, Ndrepepa G, Deisenhofer I, Weyerbrock S, Schreieck J, Schomig A (1999) Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias. Circulation 99:2414–2422
Tracy CM, Swartz JF, Fletcher RD, Hoops HG, Solomon AJ, Karasik PE, Mukherjee D (1993) Radiofrequency catheter ablation of ectopic atrial tachycardia using paced activation sequence mapping. J Am Coll Cardiol 21:910–917
O’Hara GE, Philippon F, Champagne J, Blier L, Molin F, Cote JM, Nault I, Sarrazin JF, Gilbert M (2007) Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec heart institute, Laval Hospital. Can J Cardiol 23(Suppl B):67B–70B
Swallow EB, Dayer MJ, Oldfield WL, Moxham J, Polkey MI (2006) Right hemi-diaphragm paralysis following cardiac radiofrequency ablation. Respir Med 100:1657–1659
Lee JC, Steven D, Roberts-Thomson KC, Raymond JM, Stevenson WG, Tedrow UB (2009) Atrial tachycardias adjacent to the phrenic nerve: recognition, potential problems, and solutions. Heart Rhythm 6:1186–1191; Bastani H, Insulander P, Schwieler J, Tabrizi F, Braunschweig F, Kenneback G, Drca N, Sadigh B, Jensen-Urstad M (2009) Safety and efficacy of cryoablation of atrial tachycardia with high risk of ablation-related injuries. Europace 11:625–629
Calkins H, Langberg J, Sousa J, el-Atassi R, Leon A, Kou W, Kalbfleisch S, Morady F (1992) Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation 85:1337–1346
Lesh MD, Van Hare GF, Schamp DJ, Chien W, Lee MA, Griffin JC, Langberg JJ, Cohen TJ, Lurie KG, Scheinman MM (1992) Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol 19:1303–1309
Weng KP, Wolff GS, Young ML (2003) Multiple accessory pathways in pediatric patients with Wolff-Parkinson-White syndrome. Am J Cardiol 91:1178–1183
Chen YJ, Chen SA, Tai CT, Chiang CE, Lee SH, Chiou CW, Ueng KC, Wen ZC, Yu WC, Huang JL, Feng AN, Chang MS (1997) Long-term results of radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome. Zhonghua Yi Xue Za Zhi (Taipei) 59:78–87
Lin JL, Schie JT, Tseng CD, Chen WJ, Cheng TF, Tsou SS, Chen JJ, Tseng YZ, Lien WP (1995) Value of local electrogram characteristics predicting successful catheter ablation of left-versus right-sided accessory atrioventricular pathways by radiofrequency current. Cardiology 86:135–142
Grimm W, Miller J, Josephson ME (1994) Successful and unsuccessful sites of radiofrequency catheter ablation of accessory atrioventricular connections. Am Heart J 128:77–87
Silka MJ, Kron J, Halperin BD, Griffith K, Crandall B, Oliver RP, Walance CG, McAnulty JH (1992) Analysis of local electrogram characteristics correlated with successful radiofrequency catheter ablation of accessory atrioventricular pathways. Pacing Clin Electrophysiol 15:1000–1007
Calkins H, Kim YN, Schmaltz S, Sousa J, el-Atassi R, Leon A, Kadish A, Langberg JJ, Morady F (1992) Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation 85:565–573
Haissaguerre M, Fischer B, Warin JF, Dartigues JF, Lemetayer P, Egloff P (1992) Electrogram patterns predictive of successful radiofrequency catheter ablation of accessory pathways. Pacing Clin Electrophysiol 15:2138–2145
Swartz JF, Tracy CM, Fletcher RD (1993) Radiofrequency endocardial catheter ablation of accessory atrioventricular pathway atrial insertion sites. Circulation 87:487–499
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Almuti, K., Bozorgnia, B., Rothman, S.A. (2011). Supraventricular Arrhythmias. In: Yan, GX., Kowey, P. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-161-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-161-5_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-160-8
Online ISBN: 978-1-60761-161-5
eBook Packages: MedicineMedicine (R0)